Eli Lilly : LLY

All Eli Lilly Articles

652 Articles

Michael Williams | Mar 28, 2026 at 7:15 AM EDT

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of…

Michael Williams | Mar 26, 2026 at 2:32 PM EDT

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

Healthcare spending doesn’t stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT),…

Michael Williams | Mar 25, 2026 at 10:45 AM EDT

3 Equal Weight ETFs Beating the S&P 500 in 2026 as Mega-Cap Dominance Fades

The S&P 500 you own through a standard index fund is not as diversified as it looks. The cap-weighted version…

John Seetoo | Mar 24, 2026 at 10:07 AM EDT

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

Half of every dollar invested in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) rides on just two companies pulling in opposite directions…

David Moadel | Mar 23, 2026 at 9:34 AM EDT

NVIDIA’s Monday Rebound: What Energy Partnerships and BioNeMo Mean for NVDA Stock

NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) shares are up roughly 2% in Monday morning trading, offering a modest but welcome…

Chris MacDonald | Mar 20, 2026 at 10:02 AM EDT

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

Growth investing has had a choppy start to 2026. The major growth benchmarks are down in the low single digits…

Chris MacDonald | Mar 18, 2026 at 7:00 AM EDT

3 Growth ETFs to Buy in 2026 and Hold Until Your Portfolio Hits 7 Figures

Building a seven-figure portfolio from scratch requires one thing above almost everything else: time in the market, compounded through funds…

David Moadel | Mar 17, 2026 at 12:27 PM EDT

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Eli Lilly (NYSE:LLY | LLY Price Prediction) stock is down 5% in Tuesday afternoon trading, with shares falling to $937…

Joel South | Mar 17, 2026 at 12:25 PM EDT

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216

Eli Lilly (NYSE:LLY | LLY Price Prediction) shares have pulled back sharply, falling 9% over the past month, and 13%…

Rich Duprey | Mar 16, 2026 at 11:19 AM EDT

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Eli Lilly’s (NYSE:LLY | LLY Price Prediction) GLP-1 therapy Zepbound has become the biggest weight loss drug since its introduction,…

Austin Smith | Mar 11, 2026 at 12:37 PM EDT

Josh Brown: Biotech growth stocks immune to disruption risk

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap biotech:…

Joey Frenette | Mar 4, 2026 at 3:30 PM EST

Forget AI. This Biotech Stock’s Taking Off Right Now

The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is…

Trey Thoelcke | Mar 2, 2026 at 10:40 AM EST

What Smart Money Loves About Lilly

Eli Lilly (NYSE: LLY | LLY Price Prediction) stock has pulled back 2.9% year-to-date to around $1,044, and institutional investors…

Lee Jackson | Feb 27, 2026 at 8:11 AM EST

5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years

Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return. Total…

Lee Jackson | Feb 25, 2026 at 7:57 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

Pre-Market Stock Futures: Futures are trading higher this morning, but what a difference a day makes after a “Meltdown Monday.” …

1 2 3 4 5 6 … 44

Eli Lilly : LLY

All Eli Lilly Articles

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

3 Equal Weight ETFs Beating the S&P 500 in 2026 as Mega-Cap Dominance Fades

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

NVIDIA’s Monday Rebound: What Energy Partnerships and BioNeMo Mean for NVDA Stock

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

3 Growth ETFs to Buy in 2026 and Hold Until Your Portfolio Hits 7 Figures

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Josh Brown: Biotech growth stocks immune to disruption risk

Forget AI. This Biotech Stock’s Taking Off Right Now

What Smart Money Loves About Lilly

5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

69-Year-Old Widow Discovers Husband’s IRA Will Cost $112,000 in Avoidable Tax

Three Index ETFs Where You Can Sell Your Own 0DTE Covered Calls for Daily Premium Income

Summer Is Secretly the Best Time to Buy These Things

69-Year-Old Widow Discovers Husband's IRA Will Cost $112,000 in Avoidable Tax

When Your Paychecks Stop, an 8-Month Medicare Clock Starts — and Most People Read It Wrong

69-Year-Old Widow Discovers Husband’s IRA Will Cost $112,000 in Avoidable Tax

Three Index ETFs Where You Can Sell Your Own 0DTE Covered Calls for Daily Premium Income

Eli Lilly : LLY

All Eli Lilly Articles

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

3 Equal Weight ETFs Beating the S&P 500 in 2026 as Mega-Cap Dominance Fades

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

NVIDIA’s Monday Rebound: What Energy Partnerships and BioNeMo Mean for NVDA Stock

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

3 Growth ETFs to Buy in 2026 and Hold Until Your Portfolio Hits 7 Figures

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Josh Brown: Biotech growth stocks immune to disruption risk

Forget AI. This Biotech Stock’s Taking Off Right Now

What Smart Money Loves About Lilly

5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

69-Year-Old Widow Discovers Husband’s IRA Will Cost $112,000 in Avoidable Tax

Three Index ETFs Where You Can Sell Your Own 0DTE Covered Calls for Daily Premium Income

Summer Is Secretly the Best Time to Buy These Things

Featured Reads

69-Year-Old Widow Discovers Husband's IRA Will Cost $112,000 in Avoidable Tax

When Your Paychecks Stop, an 8-Month Medicare Clock Starts — and Most People Read It Wrong